Professor Guo Weiqin’s academic thought in treating chest pain after percutaneous coronary intervention from the perspective of "toxin, stasis and deficiency"

WANG Zhimiao; ZHU Haiyan; ZHAO Yong; LIANG Jinpu; MENG Wei; GAO Yuqian; ZHANG Dongmei

doi:10.3969/j.issn.2095-6606.2023.04.008

您当前的位置：

首页 >

文章列表页 >

Professor Guo Weiqin’s academic thought in treating chest pain after percutaneous coronary intervention from the perspective of "toxin, stasis and deficiency"

Renowned TCM Doctors’ Experience | 更新时间：2023-08-07

- Professor Guo Weiqin’s academic thought in treating chest pain after percutaneous coronary intervention from the perspective of "toxin, stasis and deficiency"
- Modern Chinese Clinical Medicine Vol. 30, Issue 4, Pages: 38-41(2023)
- 作者机构：
  
  1.北京中医药大学东直门医院　北京　100700
  2.北京中医药大学
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.2095-6606.2023.04.008
  CLC： R259
- Received：24 October 2022，
  
  Published：30 July 2023
- 稿件说明：
移动端阅览
WANG Zhimiao, ZHU Haiyan, ZHAO Yong, et al. Professor Guo Weiqin’s academic thought in treating chest pain after percutaneous coronary intervention from the perspective of "toxin, stasis and deficiency"[J]. Modern Chinese Clinical Medicine, 2023, 30(4): 38-41.
DOI：

WANG Zhimiao, ZHU Haiyan, ZHAO Yong, et al. Professor Guo Weiqin’s academic thought in treating chest pain after percutaneous coronary intervention from the perspective of "toxin, stasis and deficiency"[J]. Modern Chinese Clinical Medicine, 2023, 30(4): 38-41. DOI： 10.3969/j.issn.2095-6606.2023.04.008.

摘要

经皮冠状动脉介入治疗(PCI)是临床治疗冠心病的常用手段，但术后患者易出现胸痛等不适，尚未得到有效解决。郭维琴教授对于PCI术后胸痛的诊治有独到见解，认为“毒”“瘀”“虚”是冠脉介入术后胸痛的关键病机，据此创新性地提出了分期防治的观点。治疗上以益气活血法贯穿始终，术后早期以清热解毒为主，中期重视活血化瘀，后期不忘补益正气，临床疗效显著。

Abstract

Percutaneous coronary intervention (PCI) is a common method for clinical treatment of coronary heart disease

but patients are prone to postoperative chest pain and other types of discomfort

for which there are currently no effective measures. Professor Guo Weiqin has developed unique insights into the diagnosis and treatment of chest pain after PCI. She believes that toxin

stasis and deficiency are the key contributing factors of the pain

and

based on this theory

proposed an innovative way of staged prevention and treatment. The method of boosting qi and invigorating blood is used throughout the treatment

with special focus placed on clearing heat and removing toxins in the early stage after operation

activating blood and removing stasis in the middle

and supplementing and invigorating healthy qi in the later stage.

关键词

Keywords

references

任晓园，王慧峰，郝佳，等 . PCI术后发生支架内再狭窄的危险因素及预防措施研究进展 [J]. 中西医结合心脑血管病杂志， 2021 , 19 ( 11 ): 1834 - 1836 .

张仲景 . 金匮要略 [M]. 文棣，校注. 北京：中国书店出版社， 1993 : 47 - 48 .

郭维琴 . 中医药防治PTCA后RS的研究 [J]. 中医药学刊， 2005 , 23 ( 9 ): 1549 - 1550 .

CREA F ， BAIREY M C ， BELTRAME J F ， et al . Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization [J]. Eur Heart J ， 2019 , 40 ( 29 ): 2455 - 2462 .

JAKIMIV T ， MRDOVIC I ， FILIPOVIC B ， et al . Comparison of RISK-PCI，GRACE，TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome [J]. Croat Med J ， 2017 , 58 ( 6 ): 406 - 415 .

李刚 . 急性冠脉综合征患者冠脉支架植入术后再狭窄的影响因素 [J]. 黑龙江医学， 2022 , 46 ( 8 ): 930 - 931 .

马征，龙佳，贾文浩，等 . 益气凉血生肌方预防冠心病PCI术后气虚血瘀、痰热互结证患者主要不良心血管事件的随机对照试验 [J]. 中医杂志， 2019 , 60 ( 21 ): 1837 - 1842 .

PADRO T ， MANFRINI O ， BUGIARDINI R ， et al . ESC working group on coronary pathophysiology and microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease [J]. Cardiovasc Res ， 2020 , 116 ( 4 ): 741 - 755 .

王士雄 . 温热经纬 [M]. 达美君，校注. 北京：中国中医药出版社， 1996 : 214 .

梁晋普，王亚红，秦建国 . 郭维琴教授益气活血法治疗冠心病临证经验 [J]. 北京中医药大学学报(中医临床版) ， 2013 , 20 ( 5 ): 44 - 46 .

黄元御 . 四圣心源 [M]. 赵文举，吕宇剑，校注. 沈阳：辽宁科学技术出版社， 2017 : 33 .

靳贵林，陈正红，罗珍，等 . 红芪和黄芪的药理药效研究比较 [J]. 西藏科技， 2020 ( 3 ): 51 - 55 .

李时珍 . 本草纲目 [M]. 长春：吉林大学出版社， 2004 .

单晓晓，洪帮振，刘洁，等 . 丹参化学成分、药理作用、临床应用的研究进展及质量标志物的预测分析 [J]. 中国中药杂志， 2021 , 46 ( 21 ): 5496 - 5511 .

张树蓉，赵宏苏，佟沫儒，等 . 牡丹皮化学成分、药理作用及其质量标志物(Q-Marker)的预测分析 [J]. 中草药， 2022 , 53 ( 16 ): 5215 - 5224 .

吴玲芳，王子墨，赫柯芊，等 . 赤芍的化学成分和药理作用研究概况 [J]. 中国实验方剂学杂志， 2021 , 27 ( 18 ): 198 - 206 .

赵佩媛，韩立柱，汪芸兰，等 . 连翘的研究进展及质量标志物的预测分析 [J]. 中华中医药学刊， 2022 , 40 ( 4 ): 19 - 27 .

张山雷 . 本草正义 [M]. 王国炜，郝鸿宇，郭海，等，校注. 太原：山西科学技术出版社， 2013 : 93 .

杨丽霞，郭瑞威 . 《中国经皮冠状动脉介入治疗指南(2016)》指导急性冠状动脉综合征的临床实践 [J]. 中国介入心脏病学杂志， 2016 , 24 ( 12 ): 714 - 717 .

贾所学 . 药品化义 [M]. 李延昰，补订. 北京：中国中医药出版社， 2015 : 35 .

费程浩，童黄锦，李昱，等 . 莪术治疗冠心病的物质基础及作用机制预测研究 [J]. 中国中药杂志， 2022 , 47 ( 12 ): 3270 - 3284 .

Views

1172

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Professor Guo Weiqin’s experience in treating sick sinus syndrome

Zhai Shuangqing's experience in treating bipolar disorder based on the“Five Stagnations”

Jiang Liangduo's treatment for neurogenic tinnitus through the lens of the “Triple-Jiao Toxin-Discharging” theory

Liu Likun's approach to managing treatment-induced menopausal symptoms in breast cancer endocrine therapy through the lens of“deficiency, stagnation, and fire”

Professor Zhao Jinxi’s experience in the treatment of abnormal urination with Shengxian Decoction

Related Author

Yingfei LI

Xiaoyun CUI

Qian LIN

Jie WAN

Xing LI

Huiqing LIU

HU Dongsen

WANG Liyuan

Related Institution

Dongfang Hospital, Beijing University of Chinese Medicine

北京中医药大学第一临床医学院北京 100029First Clinical Medical College，Beijing University of Chinese Medicine，Beijing

北京中医药大学Beijing University of Chinese Medicine

北京中研集团东城中医医院Dongcheng Hospital of Traditional Chinese Medicine，Beijing Zhongyan Group

北京中医药大学第三附属医院Third Affiliated Hospital，Beijing University of Chinese Medicine

AI问答

⁰